Applied Genetic Technologies Corporation (AGTC) Fundamentals

Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.
SHARE INFORMATION
Market Cap$ 45,830,162
Shares Outstanding50,252,371
Float50,120,792
Percent Float99.74%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 500,000
Latest Fiscal EPS$ -1.82
Latest Fiscal Date2021-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions168
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months876,162
Institutional Holdings Percent41.0%
Institutional Sold Previous 3 Months4,645,077
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months120,686
Insider Holdings Percent0.8
Insider Sold Previous 3 Months130,636
Insider Shares Owned401,849
TRADING INFO
52 Week High$ 4.65
52 Week Low$ 0.58
52 Week High Change$ -77.76
21 Day Moving Average$ 0.8557
21 Day Extended Moving Average$ 0.868139
50 Day Moving Average$ 1.1052
50 Day Extended Moving Average$ 1.106
200 Day Moving Average$ 2.1753
200 Day Extended Moving Average$ 2.1116
10 Day Average Volume492,772
20 Day Average Volume456,006
30 Day Average Volume500,230
50 Day Average Volume669,477
Alpha-0.022487
Beta1.6543
Standard Deviation0.220411
R20.126229
7 Day Price Change$ 0.2815
7 Day Percent Change44.65%
21 Day Price Change$ -0.0275
21 Day Percent Change-2.93%
30 Day Price Change$ -0.168
30 Day Percent Change-15.56%
Month to Date Price Change$ 0.0116
Month to Date Percent Change1.29%
Quarter to Date Price Change$ -0.158
Quarter to Date Percent Change-14.77%
180 Day Price Change$ -1.69
180 Day Percent Change-64.92%
200 Day Price Change$ -1.68
200 Day Percent Change-64.79%
Year to Date Price Change$ -0.988
Year to Date Percent Change-52.0%

Applied Genetic Technologies Corporation (AGTC) Key Ratios

PROFITABILITY
EBIT Margin-12,621.4%
EBITDA Margin-12,333.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 500,000
Revenue Per Share$ 0.0099
Revenue (3 Years)$ -77.54
Revenue (5 Years)$ -60.64
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.50
Int Coverage-29.00
Current Ratio3.10
Leverage Ratio1.80
Quick Ratio3.00
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ -6,592,315
Price to Sales92.535
Price to Free Cash-0.90
PE High Last 5 Years575.00
Price To Book0.80
Price To Cash Flow1.80
PE Low Last 5 Years-47.00
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.90
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-79.48
Return on Equity-140.51
Return on Capital-92.52

Applied Genetic Technologies Corporation (AGTC) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOSusan B. Washer
Emplyoees83
Last AuditUQ
CIK0001273636
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address14193 NW 119th Terrace
Suite 10
Alachua, FL 32615
Websitehttps://www.agtc.com
Facsimile-
Telephone+1 386 462-2204
Emailbsullivan@agtc.com
Your Recent History
NASDAQ
AGTC
Applied Ge..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220520 13:16:55